Capillary Tech. Q1 FY27 Results (NSE: CAPILLARY)
Signal: Slipped to loss
The read
Consolidated revenue growth (42.7% YoY) and EBITDA margin expansion (734bps) are the real trajectory, but the ₹33.39 Cr exceptional acquisition charge masks the operational improvement and swung PAT to a loss. Standalone profit shows the parent is solid but dependent on other income.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹256.64 Cr | 42.66% | 34.13% |
| EBIT | ₹25.96 Cr | 1410% | |
| Net profit | ₹-9.55 Cr | -1382.6% | |
| EPS | ₹-1.2 | -1300% | |
| EBIT margin | 10.1% |
P&L walk
Revenue grew 42.7% YoY on organic momentum and acquisitions; EBITDA margin expanded 734bps YoY on operating leverage (employee cost +39.8% vs revenue +42.7%), but PAT swung to a ₹9.55 Cr loss due to a ₹33.39 Cr exceptional charge for Session M acquisition.
Key positives
- Revenue grew 42.7% YoY to ₹256.64 Cr, driven by organic strength and acquisitions.
- EBITDA margin expanded 734bps YoY to 17.9% on operating leverage (employee cost +39.8% vs revenue +42.7%).
- Standalone EBITDA margin of 30.7% and PAT of ₹7.77 Cr highlight core business health.
Key concerns
- Consolidated net loss of ₹9.55 Cr due to exceptional charge of ₹33.39 Cr from Session M acquisition.
- Standalone other income at 60.1% of PBT signals lower core operating profitability.
- EPS turned negative to ₹-1.20 vs ₹0.10 in Q1FY26.
Research and educational content only. Not investment advice.